Landos Biopharma, Inc.
LABP · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$21,935 | -$39,276 | -$38,422 | -$30,144 |
| Dep. & Amort. | $44 | $577 | $196 | $137 |
| Deferred Tax | $2,129 | $0 | $0 | $293 |
| Stock-Based Comp. | $971 | $1,971 | $4,118 | $833 |
| Change in WC | $443 | -$10,074 | $5,891 | $5,871 |
| Other Non-Cash | -$2,129 | $1,031 | $1,156 | $48 |
| Operating Cash Flow | -$20,477 | -$45,771 | -$27,061 | -$22,962 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$7 | -$440 | -$181 |
| Net Acquisitions | $0 | $236 | -$235 | $88 |
| Inv. Purchases | $0 | -$3,671 | -$174,853 | -$21,718 |
| Inv. Sales/Matur. | $7,775 | $77,502 | $116,587 | $36,030 |
| Other Inv. Act. | -$57 | $0 | $235 | -$88 |
| Investing Cash Flow | $7,775 | $74,060 | -$58,706 | $14,131 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $16,567 | $0 | $93,000 | $1,518 |
| Stock Repurch. | -$3,000 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $13,567 | $0 | $91,607 | $1,518 |
| Financing Cash Flow | $13,567 | $0 | $91,607 | $1,518 |
| Forex Effect | $44 | $46 | $49 | -$79 |
| Net Chg. in Cash | $909 | $28,335 | $5,889 | -$7,392 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $36,640 | $8,305 | $2,416 | $9,808 |
| End Cash | $37,549 | $36,640 | $8,305 | $2,416 |
| Free Cash Flow | -$20,477 | -$45,778 | -$27,501 | -$23,143 |